We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LZB:NYSELa-Z-Boy Incorporated Analysis

Data as of 2026-05-19 - not real-time

$34.55

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

La‑Z‑Boy (LZB) trades at $34.55, well below its DCF‑derived fair value of $65.83, implying ~28% upside. The stock’s trailing P/E of 17.3 is modest for the consumer cyclical space and aligns with a value narrative. A dividend yield of 2.8% with a 45% payout ratio suggests sustainable income. Technicals show the 20‑day SMA ($35.24) just above price, while the 50‑day SMA ($33.94) sits below, indicating a neutral bias. The MACD histogram is negative and the signal line is bearish, hinting at short‑term pressure. RSI at 48 is neither overbought nor oversold, supporting a wait‑and‑see stance.
Volatility is elevated at 31.6% over the past 30 days, but beta near 0.94 suggests market‑level risk rather than excess. The price sits above the identified support of $33.48 and below resistance at $36.80, giving a modest technical cushion. Operating margins are thin (5.4%) yet cash flow remains healthy, with free cash flow exceeding $190 M. The recent sale of the American Drew and Kincaid casegoods businesses reduces exposure to lower‑margin wholesale segments. Management’s declaration of a quarterly dividend reinforces shareholder commitment. Combined, these fundamentals and valuation gaps support a buy recommendation across horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bearish MACD signal
  • Price near support level
  • Sustainable dividend

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant DCF upside
  • Improving cash flow after casegoods divestiture
  • Attractive dividend yield

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term undervaluation relative to fair value
  • Stable earnings and free cash flow generation
  • Strategic focus on higher‑margin retail and e‑commerce

Key Metrics & Analysis

Financial Health

Revenue Growth3.80%
Profit Margin3.93%
P/E Ratio17.3
ROE8.09%
ROA4.31%
Debt/Equity53.88
P/B Ratio1.4
Op. Cash Flow$237.7M
Free Cash Flow$194.7M

Technical Analysis

TrendNeutral
RSI48.2
Support$33.48
Resistance$36.80
MA 20$35.24
MA 50$33.94
MA 200$35.44
MACDBearish
VolumeStable
Fear & Greed Index89.61

Valuation

Fair Value$65.83
Target Price$44.50
Upside/Downside28.80%
GradeUndervalued
TypeValue
Dividend Yield2.80%

Risk Assessment

Beta0.94
Volatility31.65%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.